Clinical Trial Update: Stellate Ganglion Block in the Treatment of Posttraumatic Stress Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating stellate ganglion block as a treatment for posttraumatic stress disorder. The study is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Snippet

Sponsor: The Royal's Institute of Mental Health Research | Conditions: PTSD | Phase 3 | Status: ENROLLING_BY_INVITATION